XML 39 R29.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 13, 2025
Oct. 08, 2025
Sep. 30, 2025
Jun. 16, 2025
Jun. 05, 2025
Mar. 20, 2025
Feb. 14, 2025
Feb. 06, 2024
Feb. 05, 2024
Sep. 30, 2025
Jun. 30, 2025
 [1]
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Oct. 06, 2025
Dec. 31, 2024
Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Cash issuance costs                             $ 72,805      
Shares held in abeyance     1,138,055     1,138,055       1,138,055     1,201,580   1,138,055 1,201,580     1,351,580
Weighted average grant date fair value of stock options granted                   $ 0     $ 0   $ 1.87 $ 1.11      
Issuance and sale of common stock, net of issuance costs                     $ 888,138 $ 901,610 [2]              
Net proceeds from shares sold                             $ 2,011,250      
Deferred offering costs reclassified to additional paid-in capital                             148,697        
Repurchase of common stock     $ 0                                
Gross proceeds from exercise of options                             $ 42,411      
Subsequent Event [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Exercise price   $ 2.75                             $ 2.75    
Number of shares sold   678,125                                  
Share-Based Payment Arrangement, Option [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Options granted                             2,177,908        
Exercise price of options granted                             $ 2.45        
Shares issued upon exercise of options                             29,249        
Exercise price of options exercised                             $ 1.45        
Gross proceeds from exercise of options                             $ 42,411        
Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Options granted         25,000   2,152,908                        
Exercise price of options granted         $ 1.78   $ 2.46                        
Grant date fair value of options granted         $ 34,250   $ 4,044,250                        
Vesting of options description         vests to the extent of 50% immediately with the remainder vesting quarterly over two years commencing one year from the date of grant.   vest as follows: (i) options to purchase an aggregate 323,459 shares of common stock vest monthly over one year, and (ii) options to purchase an aggregate of 1,829,449 shares of common stock vest to the extent of 50% immediately with the remainder vesting quarterly over two years commencing one year from the date of grant.                        
Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member] | Subsequent Event [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Options granted 25,000                                    
Exercise price of options granted $ 1.62                                    
Vesting of options description vests as follows: (i) 50% immediately, and (ii) the remainder quarterly over two years commencing one year from the date of grant.                                    
Board of Director [Member] | Minimum [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Repurchase of common stock       $ 2,000,000                              
Common Stock [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Warrants exercisable               3,351,580                      
Exercise price               $ 2.33                      
Proceeds from exercise of warrants               $ 8,100,000                      
Cash issuance costs               $ 595,364                      
Number of shares sold                     473,337 492,087 [2]              
Shares issued                             2,213,525        
Issuance and sale of common stock, net of issuance costs                     $ 47 $ 49 [2]     $ 1,100,000        
Abeyance shares issued                       63,525   150,000          
Shares issued upon exercise of options                       29,249              
Common Stock [Member] | Subsequent Event [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Warrants exercisable   508,592                                  
Common Stock [Member] | Roth Capital Partners LLC [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Cash fee for services                 $ 528,000                    
Common Stock [Member] | Private Placement [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Warrants exercisable               2,513,686                      
Exercise price               $ 2.43                      
Warrants for cash and the payment               $ 0.125                      
Common Stock [Member] | 2024 ATM Program [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Number of shares sold                   0         965,424        
Issuance and sale of common stock, net of issuance costs                             $ 2,011,250        
Commissions, legal and accounting fees                             72,805        
Net proceeds from shares sold                             $ 1,938,445        
Common Stock [Member] | Auctus Fund, LLC [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Shares held in abeyance                                   1,201,580  
Number of shares sold           63,525                          
Abeyance shares issued                   0         63,525        
Warrant [Member] | Roth Capital Partners LLC [Member]                                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                                      
Issuance costs                               $ 595,364      
[1] Represents the gross proceeds of $927,335, less issuance costs of $39,197, resulting in net proceeds of $888,138. See Note 4 - Stockholders’ Equity - ATM Sales for additional details.
[2] Represents the gross proceeds of $1,083,915, less issuance costs of $182,305, resulting in net proceeds of $901,610. See Note 4 - Stockholders’ Equity - ATM Sales for additional details.